These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6239348)

  • 1. [Special clinico-therapeutic aspects of chronic hepatic encephalopathy (chronic progressive hepatocerebral degeneration)].
    Constantinovici A; Drăghici L; Moldovan M; Răduţoiu E; Oşanu M
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1984; 29(3):185-9. PubMed ID: 6239348
    [No Abstract]   [Full Text] [Related]  

  • 2. Lactulose in the treatment of chronic hepatic encephalopathy: report of three cases.
    Juttijudata P; Meensook C
    J Med Assoc Thai; 1981 Dec; 64(12):636-9. PubMed ID: 6153032
    [No Abstract]   [Full Text] [Related]  

  • 3. [The role of neuropsychological testing and electroencephalogram for early detection of minimal hepatic encephalopathy].
    Choi CS; Kim BI; Lee MH; Choi HS; Kim SH; Ahn DH
    Korean J Hepatol; 2005 Dec; 11(4):329-38. PubMed ID: 16380662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic acquired hepatocerebral degeneration: case reports and new insights.
    Jog MS; Lang AE
    Mov Disord; 1995 Nov; 10(6):714-22. PubMed ID: 8749990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Milk protein in the treatment of chronic portasystemic encephalopathy. A long-term study of therapeutic measures in a patient with chronic porta-systemic encephalopathy.
    Van Der Zwan JC; Gips CH; Qué GS; Boonstra S
    Neth J Med; 1974; 17(2):42-9. PubMed ID: 4839373
    [No Abstract]   [Full Text] [Related]  

  • 6. [Early symptoms of hepatic encephalopathy in patients with chronic diffuse hepatic diseases].
    Maev IV; Nikushina IN; Samsonov AA; V'iuchnova ES; Andreev NG
    Klin Med (Mosk); 2007; 85(8):55-7. PubMed ID: 17926493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effectiveness of various hepatoprotective agents in liver encephalopathy].
    Liubshina OV; Grechko VE; Vertkin AL; Maev IV
    Klin Med (Mosk); 1999; 77(10):17-20. PubMed ID: 10635647
    [No Abstract]   [Full Text] [Related]  

  • 8. [Definitions and criteria for acute and chronic portal systemic encephalopathy].
    Valdovinos Díaz MA
    Rev Invest Clin; 1990 Jul; 42 Suppl():110-2. PubMed ID: 19256148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of cirrhotic hepatic encephalopathy with L-dopa. A controlled trial.
    Michel H; Solere M; Granier P; Cauvet G; Bali JP; Pons F; Bellet-Hermann H
    Gastroenterology; 1980 Aug; 79(2):207-11. PubMed ID: 6995221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anatomo-clinical study of 72 cases of hepatic coma. Comparison with the biologic and electrencephalographic data].
    Mahoudeau D; Dubrisay J; Foncin JF; Pouillart P
    Bull Mem Soc Med Hop Paris; 1968; 119(6):499-510. PubMed ID: 5674318
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful use of bromocriptine in the treatment of chronic hepatic encephalopathy.
    Morgan MY; Jakobovits AW; James IM; Sherlock S
    Gastroenterology; 1980 Apr; 78(4):663-70. PubMed ID: 7353752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of minimal hepatic encephalopathy: normalization and optimization of the Psychometric Hepatic Encephalopathy Score. A neuropsychological and quantified EEG study.
    Amodio P; Campagna F; Olianas S; Iannizzi P; Mapelli D; Penzo M; Angeli P; Gatta A
    J Hepatol; 2008 Sep; 49(3):346-53. PubMed ID: 18602716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of acute and chronic portal encephalopathy with the precursors of dopamine.
    Szczerbań J; Rózga J
    Acta Med Pol; 1979; 20(3):249-56. PubMed ID: 517163
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatic encephalopathy coexists with acquired chronic hepatocerebral degeneration.
    Huang FZ; Hou X; Zhou TQ; Chen S
    Neurosciences (Riyadh); 2015 Jul; 20(3):277-9. PubMed ID: 26166598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bromocriptine to treat "intractable" portal systemic encephalopathy.
    Uribe M
    Gastroenterology; 1980 Sep; 79(3):602-3. PubMed ID: 7429126
    [No Abstract]   [Full Text] [Related]  

  • 16. [Study on subclinical hepatic encephalopathy in patients with hepatic failure].
    Zhang LH; Chong YT; Zhuang P; Zhang WD; Mei YY; Shu X
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):198. PubMed ID: 12716510
    [No Abstract]   [Full Text] [Related]  

  • 17. Case of pediatric acquired chronic hepatocerebral degeneration.
    Papapetropoulos S; Tzakis A; Sengun C; Reddy C; Boukas K; Zitser J; Singer C
    Pediatr Neurol; 2008 Jan; 38(1):67-70. PubMed ID: 18054700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subclinical hepatic encephalopathy: how best to diagnose?
    Chalasani N; Gitlin N
    Am J Gastroenterol; 1997 May; 92(5):905-6. PubMed ID: 9149218
    [No Abstract]   [Full Text] [Related]  

  • 19. [Complex therapy of chronic hepatic encephalopathy supplemented with probiotic: comparison of two studies].
    Boca M; Vyskocil M; Mikulecký M; Ebringer L; Kolibás E; Kratochvíl'ová H; Buzgová D
    Cas Lek Cesk; 2004; 143(5):324-8. PubMed ID: 15305769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current and future diagnosis of hepatic encephalopathy.
    Bajaj JS
    Metab Brain Dis; 2010 Mar; 25(1):107-10. PubMed ID: 20213105
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.